Among children, adolescents and adults with peanut allergy, a once-daily peanut sublingual immunotherapy tablet was well tolerated up to the highest dose in an up-dosing regimen, according to phase ...

Credit: Getty Images. The study included 1458 children aged 5 to 11 years with a clinical history of HDM-induced allergic rhinitis. ALK’s sublingual allergy immunotherapy tablet was found to be ...

Merck announced data for its investigational Timothy grass sublingual allergy immunotherapy tablet (MK-7243), a once-daily tablet designed to help treat the underlying cause of allergic rhinitis in ...

A string of FDA approvals and late-stage clinical trials has expanded the toolkit for treating seasonal and environmental allergies, giving patients new ways to manage symptoms and, in some cases, ...

ORALAIR® (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass Mixed Pollens Allergenic Extract) is the Only Sublingual Allergy Immunotherapy Tablet with a Mix of Five Grass Allergen ...

First sublingual tablet for grass allergies approved The FDA has cleared the once-daily tablet Oralair to treat grass-pollen induced allergic rhinitis with or without conjunctivitis. HealthDay News — ...

WHITEHOUSE STATION, N.J.--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved GRASTEK® (Timothy Grass ...

Stallergenes filed with the FDA to sell a first-of-its-kind sublingual allergy medication in the U.S., furthering the company's ongoing international expansion. The French company is seeking a ...

HOUSTON, Texas (KTRK) -- An exciting new and not so traditional treatment takes a different approach, offering allergy sufferers an alternative treatment. Sublingual immunotherapy also known as "Slit, ...

Dust mite allergies are a common trigger for asthma. A new form of immunotherapy that relies on oral tablets rather than shots reduces the risk of... Immunotherapy Tablets For Dust Mite Allergy Reduce ...

STALLERGENES S.A. (Paris:GENP) (Euronext Paris), the world leader in sublingual immunotherapy, today announced that the U.S. Food and Drug Administration (FDA) has approved ORALAIR(R) , the first ...

Immunotherapy tablets are starting to edge out shots as a treatment for allergies. And it looks like the pills can help reduce the frequency of asthma attacks, too. Scientists reported Tuesday that ...